S. Giaquinta

Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study)

Carmine Pinto, Francesca Di Fabio, Salvatore Siena et al. · Annals of Oncology · 2006 · 285 citations · Full text

Medicine, Oncology, Pharmacology +16

Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study)

Carmine Pinto, Francesca Di Fabio, Carlo Barone et al. · British Journal of Cancer · 2009 · 142 citations · Full text

Medicine, Oncology, Pharmacology +17

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer

Emilio Bajetta, Irene Floriani, Maria Di Bartolomeo et al. · Annals of Oncology · 2014 · 90 citations · Full text

Medicine, Oncology, Chemotherapy +10

Prospective study on the FDG–PET/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer

Andrea Martoni, Francesca Di Fabio, Carmine Pinto et al. · Annals of Oncology · 2010 · 86 citations · Full text

Medicine, Oncology, Surgery +17

Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer

Andrea Martoni, Antonella Marino, Francesca Sperandi et al. · European Journal of Cancer · 2004 · 73 citations

Medicine, Oncology, Pharmacology +9